个性化血液透析治疗与增量透析的病例患者末期脏疾病:一个实施研究协议

Marni Armstrong1,2, Tracy Lynn Wityk Martin3, Gabrielle L Zimmermann2,4

  • 1Medicine Strategic Clinical Network, Alberta Health Services, Edmonton, Alberta, Canada marni.armstrong@ahs.ca.

BMJ open
|January 29, 2024
PubMed
概括

增量透析,个性化用于残留功能,提供更短,更少的治疗频率,改善生活质量和降低成本. 这项研究实施和评估了系统的增量透析护理,以获得更好的患者结果.